Key Takeaways

• Bayesian Optimization is a sequential, model-guided search that selects the next experiment based on what prior experiments have revealed—unlike DOE, which fixes all conditions upfront.
• Bayesian Optimization performs best under exactly the conditions that define pharmaceutical and chemical process development: high dimensionality, expensive evaluations, sparse data, and noisy outcomes.
• BO and DOE are complementary, not competing. A hybrid workflow—first HTE screening, followed by BO-guided refinement, then DOE for confirmation—is often the most practical path in industrial settings.
• Running fewer experiments to reach the same outcome reduces solvent consumption, material costs, and waste, making BO directly relevant to sustainability goals in process chemistry.

The Problem BO Was Built to Solve

Chemical and pharmaceutical process development is defined by a set of constraints that are easy to state but practically difficult to manage simultaneously: data is scarce, experiments are expensive, and decisions need to happen fast. A typical reaction optimization might involve temperature, solvent choice, catalyst loading, pH, residence time, and reagent stoichiometry—each interacting with the others in ways that a straightforward grid search or classical full factorial design struggles to capture without running hundreds of reactions.

Traditional design of experiments (DOE) handles such situations by imposing structure upfront: you define your factors, select a design, run the full set, and analyze. That works well when you can afford the experimental runs and the dimensionality is modest. But when your design space is large, your materials are expensive, or you simply can't wait for a full factorial to finish, the economics break down. You end up either underexploring the space or overspending to cover it.

Bayesian optimization takes a fundamentally different approach—one built specifically for this kind of problem.

What Bayesian Optimization Actually Does

At its core, BO is a sequential strategy for finding optimal experimental conditions with as few runs as possible. It builds a probabilistic model (typically a Gaussian process) from your completed experiments, uses that model to predict outcomes across the untested design space, and—critically—quantifies its uncertainty at every point. That uncertainty estimate is what drives the entire method.

The set of next experiments are chosen by balancing two competing objectives: exploitation (testing conditions the model already knows are promising) and exploration (probing regions where uncertainties are high to better map out the entire design space). This tradeoff is managed through an acquisition function that scores every candidate point in the design space and selects the one(s) with the highest expected improvement(s).

Then the cycle repeats. Run more experiments, feed the results back in, update the model, and pick the next points to test. What emerges is a search that adapts to the actual landscape of your reaction as data comes in—not one locked into a grid that was decided before you had any results.

5 Key Challenges in Applying BO to Real Chemistry

The theory is elegant. Applying it to real process development introduces friction that's worth understanding clearly.

1. Data scarcity. Most BO algorithms assume you can generate data on demand. In practice, early-stage pharmaceutical projects might have 10–20 data points total, each representing a day or more of bench time. The surrogate model needs to learn meaningful structure from genuinely sparse datasets, which places a premium on model selection, prior specification, and intelligent initialization. 

Sunthetics addresses this by intelligently exploring the design space, selecting the most informative experiments to maximize insight from limited data.

2. Noise. Lab data is noisy. Repeat the same reaction three times, and you'll get three different yields. BO needs to separate real trends from random run-to-run variation. If the model takes every data point at face value—assuming each result is perfectly accurate—it ends up chasing noise instead of learning the actual behavior of the system. That's why robust uncertainty quantification isn't a nice-to-have here—it's essential.

Sunthetics incorporates uncertainty-aware modeling to distinguish true trends from experimental noise, ensuring more reliable decision-making.

3. High dimensionality. As the number of process parameters grows, the design space expands combinatorially. A five-variable problem with ten levels each already contains 100,000 possible conditions. BO is far more sample-efficient than brute-force search, but performance still degrades in very high dimensions without thoughtful dimensionality reduction or domain-informed constraints.

Sunthetics manages high-dimensional spaces through intelligent search strategies and constraints that focus experiments on the most promising regions.

4. Mixed variable types. Real process optimization involves both continuous parameters (temperature, concentration) and categorical ones (solvent identity, ligand choice, catalyst type). Standard BO was designed for continuous spaces, and handling categorical variables effectively—without distorting the model by assigning arbitrary numeric encodings—remains an active area of development. Approaches like chemical parameterization, which represent categorical choices through their underlying physicochemical descriptors, have shown meaningful improvements here, but that's a deeper topic warranting its own discussion.

Sunthetics handles both continuous and categorical variables using advanced encoding approaches, enabling accurate modeling of real chemical systems.

5. Experimental cost and irreversibility. Unlike a simulation you can re-run at will, every physical experiment consumes time, material, and often irreplaceable intermediates. The acquisition function needs to account not just for information value but also for practical cost—a dimension that off-the-shelf BO implementations frequently ignore.

Sunthetics prioritizes experiments based on expected value and impact, reducing unnecessary runs and minimizing material and time costs.

How BO and DOE Fit Together in Practice

This point is worth stating plainly: Bayesian optimization is not a replacement for DOE. The two methods serve different phases and have different problem structures, and the most effective workflows in industrial settings tend to use both.

A practical hybrid approach often looks like this. Early-stage screening via high-throughput experimentation generates an initial dataset across a broader design space. The first data seeds the BO loop, which then drives iterative refinement toward optimal conditions with maximum sample efficiency. Once a promising region has been identified, classical DOE—a response surface design, for instance—can confirm and characterize the ideal region(s) with the kind of structured, documentable rigor that regulatory submissions demand.

The key distinction is adaptive versus fixed. DOE maps the landscape. BO navigates it. For processes where data is expensive and the parameter space is large, each completed experiment that improves the next decision is a structural advantage that fixed designs simply cannot offer.

BO and Sustainable Process Development

There's a sustainability dimension here that deserves its own mention. Fewer experiments mean less solvent consumption, less waste, and lower material costs—which are particularly high in early-stage development where reagents are often expensive and environmental reporting requirements are tightening.

BO can also handle multi-objective optimization natively: yield and selectivity, yield and cost, and activity and toxicity profile. Instead of just improving one factor while keeping others the same and hoping it works out, multi-objective BO finds the Pareto Front—the range of conditions that best balance each goal without sacrificing the others—allowing teams to make smart choices instead of finding out by chance.

Getting Started Without a Data Science Team

One honest barrier to adoption: building a BO pipeline from scratch requires probabilistic modeling expertise that most bench scientists don't have and shouldn't need to develop. The gap between "this method could help us" and "we can actually implement it" has historically been wide.

SuntheticsML was built to close that gap. It's a no-code platform used by R&D teams at pharmaceutical and chemical companies to run Bayesian optimization on real process development problems—no custom code, no model building from scratch, no dedicated data science headcount required. If you're curious whether BO fits your workflow, the fastest way to find out is to try it on your own experimental systems.